|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000022956 |
| Receipt No. | R000026318 |
| Scientific Title | A Phase II study of Ramucirumab beyond disease progression in combination with Irinotecan after failure of weekly Paclitaxel plus Ramucirumab in advanced gastric cancer patients previously treated with fluoropyrimidine and platinum |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2017/01/04 10:11:46 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2016/06/30 19:45:42 | ||
| 2 | Update | 2016/06/30 19:46:20 | UMIN ID1 UMIN ID2 |
|
| 3 | Update | 2017/01/04 10:11:46 | Recruitment status |
